What You Should Know:
- President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
- The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling with chronic diseases, diabetes, heart disease, and obesity.
Price Reductions for Patients and
Read More
Migraines
JOGO Health and SohoMD Partner to Launch Integrated Digital Migraine Care Nationwide
What You Should Know:
- JOGO Health, a digital therapeutics company pioneering AI-driven Electromyography (EMG) biofeedback for neurology announced a strategic partnership with SohoMD, a nationwide virtual mental health provider serving over 70,000 patients across the United States.
- The collaboration is set to redefine migraine management by integrating cutting-edge neurological technology with comprehensive mental health support in a unified, accessible, and compliant care
Read More
Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention
What You Should Know:
- Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization for CT-132, the first prescription digital therapeutic specifically indicated for the preventive treatment of episodic migraine in adults aged 18 and older.
- The FDA granted a De Novo Classification Request for
Read More
Pfizer Launches PfizerForAll: Connecting Patients to Care, Medications & Vaccinations
What You Should Know:
- Pharmaceutical giant Pfizer launches PfizerForAll, a user-friendly platform designed to simplify access to healthcare and wellness management for Americans.
- PfizerForAll addresses a common frustration: the difficulty of navigating the US healthcare system.
- A recent poll by the American Academy of Physician Associates found that 65% of Americans find managing their health overwhelming, and 73% feel the system fails to meet their needs.
Read More
Highmark Grants Commercial Coverage to Theranica’s Wearable for Migraine Treatment
What You Should Know:
- Theranica, a leader in neuromodulation devices for migraine and other chronic pain conditions, announced today that Highmark Inc. has included its Nerivio Remote Electrical Neuromodulation (REN) wearable in its commercial coverage policy for the acute and preventive treatment of migraine.
- Highmark's coverage decision is a pivotal moment for migraine sufferers within their network. This opens doors for individuals previously limited by traditional treatment options
Read More
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
What You Should Know:
- ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, enabling data capture from home—where the device is intended to be used.
- Mi-Helper has been developed to meet a massive unmet need for effective, targeted, and drug-free pain management of migraines, a condition which impacts 1 billion
Read More
